Genetic MoT to screen genetic diseases

London, October 26: British scientists have managed to develop a ground-breaking universal test that would provide the impetus to prevent any genetic disease in unborn children. Soon-to-be parents will be able to detect any known genetic disease with the help of this test.

The test, developed at the Bridge Centre in London, could be used to screen out anything from the devastating Edwards syndrome to haemophilia.

The test is the brainchild and development of Professor Alan Handyside who claims that it (the test) will allow all prospective parents the choice of continuing with the artificial insemination.

The test which will cost £1,500 is likely to be available as early as next year. The "genetic MoT" will not only alter the range of innate disorders, but will also increase the speed and accuracy of existing tests.

The new test could also perk up the probability of pregnancy for those who are infertile by picking embryos that stand the best chance of developing normally.

The test entails the use of a technique known as karyomapping, which in turn generates loads of information. It thus provides a huge information data base for others to use.

Alan said, “When you start looking for more than two or three traits, you have just got no chance of getting a match. You’d need thousands of embryos, and we don’t have a practical way of making thousands of embryos.”

It is learnt that Professor Alan Handyside is planning to apply for a licence from the Human Fertilisation and Embryology Authority to market the product.

For logistical reasons, it will still be impossible to guarantee a defect-free baby. Alan said with caution, "We are still validating it, but it is going to be a revolution if it works out. It makes genetic screening very much more straightforward."